Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fst (KBSX) Cash & Equivalents (2023 - 2025)

Fst (KBSX) has disclosed Cash & Equivalents for 3 consecutive years, with $7.2 million as the latest value for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 40.82% year-over-year to $7.2 million; the TTM value through Dec 2025 reached $7.2 million, up 40.82%, while the annual FY2025 figure was $7.2 million, 40.82% up from the prior year.
  • Cash & Equivalents was $7.2 million for Q4 2025 at Fst, up from $5.1 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $8.9 million in Q4 2023, with the low at $5.1 million in Q4 2024.
  • Historically, Cash & Equivalents has averaged $7.1 million across 3 years, with a median of $7.2 million in 2025.
  • The largest annual shift saw Cash & Equivalents tumbled 42.74% in 2024 before it skyrocketed 40.82% in 2025.
  • Over 3 years, Cash & Equivalents stood at $8.9 million in 2023, then tumbled by 42.74% to $5.1 million in 2024, then skyrocketed by 40.82% to $7.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $7.2 million in Q4 2025, $5.1 million in Q4 2024, and $8.9 million in Q4 2023.